Stay updated on CD123xCD3 DuoBody Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the CD123xCD3 DuoBody Dose Escalation Clinical Trial page.

Latest updates to the CD123xCD3 DuoBody Dose Escalation Clinical Trial page
- Check4 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check11 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check33 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant revision.SummaryDifference1.0%
- Check62 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
- Check69 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
Stay in the know with updates to CD123xCD3 DuoBody Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD123xCD3 DuoBody Dose Escalation Clinical Trial page.